July 2025 Biosimilars News Summary
July 2025 saw key developments in the biosimilar landscape, including new product approvals, legislative proposals, and challenges related to understanding of biosimilars.
Browsing Tag
biosimilars
Biosimilar Pricing Future at Pharmacies
Amid rising drug prices, pharmacists and patients are turning to biosimilars. The Inflation Reduction Act could…
Etanercept Biosimilar Launch Saves Aussie Govt $6M: Pricing Policy Update
TL/DR -
The United States has approved two biosimilars for etanercept (Enbrel) but patent litigation has delayed…